Gene Xpert for direct detection of Mycobacterium Tuberculosis in stool specimens from children with presumptive pulmonary tuberculosis
dc.Affiliation | October University for modern sciences and Arts (MSA) | |
dc.contributor.author | Moussa H.S. | |
dc.contributor.author | Bayoumi F.S. | |
dc.contributor.author | Mohamed A.M.A. | |
dc.contributor.other | Faculty of Women for Art | |
dc.contributor.other | Science and Education | |
dc.contributor.other | Ain Shams University | |
dc.contributor.other | Cairo | |
dc.contributor.other | Egypt; Microbiology Department | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | MSA University | |
dc.contributor.other | Cairo | |
dc.contributor.other | Egypt; Department of Immunogenetics | |
dc.contributor.other | National Research Centre | |
dc.contributor.other | Giza | |
dc.contributor.other | Egypt; Egyptian Company of Serum and Vaccines | |
dc.contributor.other | Giza | |
dc.contributor.other | Egypt | |
dc.date.accessioned | 2020-01-09T20:41:43Z | |
dc.date.available | 2020-01-09T20:41:43Z | |
dc.date.issued | 2016 | |
dc.description | Scopus | |
dc.description.abstract | Background. Gene Xpert(GX) is a novel real time polymerase chain reaction (RT-PCR) assay which was endorsed by the World Health Organization (WHO) in 2011 for tuberculosis (TB) diagnosis and susceptibility to refampicin(RIF). Objective. To evaluate GX for direct diagnosis of TB in stool samples from children with suspected pulmonary Tuberculosis (PTB). Methods. Children older than one year and younger than 16 years with presumptive PTB were enrolled and classified to five clinical categories based on clinical, radiological, and laboratory findings: Confirmed TB, probable TB, possible TB, Unlikely TB, and not TB. Two stool samples were collected from each child and tested for the presence of Mycobacterium tuberculosis (MTB) by GX and the obtained results were compared to Lowenstien-Jensen (LJ) culture as a gold standard. Results. In total, 115 children were enrolled. 36 had been confirmed with TB, 61 probably TB, 10 possible TB, 5 unlikely TB, and 3 not TB. GX had a sensitivity of 83.33 and 80.56 % and specificity of 98.73 and 99.36 % by patients and samples respectively. GX was positive in 83.3% of confirmed TB as well as 1.6 and 0.8% of probable TB cases by patients and samples respectively. Conclusions. GX provided timely results with quit acceptable sensitivity and good specificity compared to LJ culture. In this study, sensitivity calculations take into account only children with confirmed TB. GX could not detect TB in children with probable TB, so it should not be used alone for TB diagnosis. Further studies for GX stool protocol optimization and assessment is required. � 2016 by the Association of Clinical Scientists, Inc. | en_US |
dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=26785&tip=sid&clean=0 | |
dc.identifier.doi | https://doi.org/ | |
dc.identifier.issn | 917370 | |
dc.identifier.other | https://doi.org/ | |
dc.identifier.uri | https://t.ly/ged6v | |
dc.language.iso | English | en_US |
dc.publisher | Association of Clinical Scientists | en_US |
dc.relation.ispartofseries | Annals of Clinical and Laboratory Science | |
dc.relation.ispartofseries | 46 | |
dc.subject | Children | en_US |
dc.subject | Gene Xpert | en_US |
dc.subject | Mycobacterium tuberculosis | en_US |
dc.subject | Pulmonary tuberculosis | en_US |
dc.subject | adolescent | en_US |
dc.subject | Article | en_US |
dc.subject | bacterium detection | en_US |
dc.subject | child | en_US |
dc.subject | controlled clinical trial | en_US |
dc.subject | controlled study | en_US |
dc.subject | feces analysis | en_US |
dc.subject | feces culture | en_US |
dc.subject | female | en_US |
dc.subject | gold standard | en_US |
dc.subject | human | en_US |
dc.subject | infant | en_US |
dc.subject | lung tuberculosis | en_US |
dc.subject | major clinical study | en_US |
dc.subject | male | en_US |
dc.subject | Mycobacterium tuberculosis | en_US |
dc.subject | polymerase chain reaction system | en_US |
dc.subject | priority journal | en_US |
dc.subject | real time polymerase chain reaction | en_US |
dc.subject | sensitivity and specificity | en_US |
dc.subject | demography | en_US |
dc.subject | feces | en_US |
dc.subject | genetics | en_US |
dc.subject | isolation and purification | en_US |
dc.subject | lung tuberculosis | en_US |
dc.subject | microbiology | en_US |
dc.subject | Mycobacterium tuberculosis | en_US |
dc.subject | preschool child | en_US |
dc.subject | procedures | en_US |
dc.subject | real time polymerase chain reaction | en_US |
dc.subject | reproducibility | en_US |
dc.subject | Adolescent | en_US |
dc.subject | Child | en_US |
dc.subject | Child, Preschool | en_US |
dc.subject | Demography | en_US |
dc.subject | Feces | en_US |
dc.subject | Female | en_US |
dc.subject | Humans | en_US |
dc.subject | Infant | en_US |
dc.subject | Male | en_US |
dc.subject | Mycobacterium tuberculosis | en_US |
dc.subject | Real-Time Polymerase Chain Reaction | en_US |
dc.subject | Reproducibility of Results | en_US |
dc.subject | Tuberculosis, Pulmonary | en_US |
dc.title | Gene Xpert for direct detection of Mycobacterium Tuberculosis in stool specimens from children with presumptive pulmonary tuberculosis | en_US |
dc.type | Article | en_US |
dcterms.isReferencedBy | Dye, C., Scheele, S., Dolin, P., Pathania, V., Raviglione, M.C., Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country (1999) Jama, 282 (7), pp. 677-686; (2014) Global Tuberculosis Control, , World Health Organization, Geneva; El Din, M.A.T., El Maraghy, A.A., Hay, A.H.R.A., Adverse reactions among patients being treated for multi-drug resistant tuberculosis at Abbassia Chest Hospital (2015) Egyptian Journal of Chest Diseases and Tuberculosis; Marais, B.J., Graham, S.M., Maeurer, M., Zumla, A., Progress and challenges in childhood tuberculosis (2013) The Lancet infectious diseases, 13 (4), pp. 287-289; Khan, E.A., Starke, J.R., Diagnosis of tuberculosis in children: increased need for better methods (1995) Emerging infectious diseases, 1 (4), p. 115; Welday, S.H., Kimang'a, A.N., Kabera, B.M., Mburu, J.W., Mwachari, C., Mungai, E., Stool as Appropriate Sample for the Diagnosis of Mycobacterium tuberculosis by Gene Xpert Test (2014) Open Journal of Respiratory Diseases, , 2014; Cordova, J., Shiloh, R., Gilman, R.H., Sheen, P., Martin, L., Arenas, F., Evaluation of molecular tools for detection and drug susceptibility testing of Mycobacterium tuberculosis in stool specimens from patients with pulmonary tuberculosis (2010) Journal of clinical microbiology, 48 (5), pp. 1820-1826; Lawn, S.D., Brooks, S.V., Kranzer, K., Nicol, M.P., Whitelaw, A., Vogt, M., Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study (2011) PLoS medicine, 8 (7); O'Grady, J., Maeurer, M., Mwaba, P., Kapata, N., Bates, M., Hoelscher, M., New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis (2011) Current opinion in pulmonary medicine, 17 (3), pp. 134-141; Boehme, C.C., Nabeta, P., Hillemann, D., Nicol, M.P., Shenai, S., Krapp, F., Rapid molecular detection of tuberculosis and rifampin resistance (2010) New England Journal of Medicine, 363 (11), pp. 1005-1015; Helb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology (2010) Journal of clinical microbiology, 48 (1), pp. 229-237; Boehme, C.C., Nicol, M.P., Nabeta, P., Michael, J.S., Gotuzzo, E., Tahirli, R., Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study (2011) The lancet, 377 (9776), pp. 1495-1505; Graham, S.M., Ahmed, T., Amanullah, F., Browning, R., Cardenas, V., Casenghi, M., Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel (2012) Journal of Infectious Diseases, 205, pp. S199-S208; Zar, H.J., Hanslo, D., Apolles, P., Swingler, G., Hussey, G., Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study (2005) The Lancet, 365 (9454), pp. 130-134; Kawai, V., Soto, G., Gilman, R.H., Bautista, C.T., Caviedes, L., Huaroto, L., Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru (2006) The American journal of tropical medicine and hygiene, 75 (6), pp. 1027-1033; Woods, G.L., Brown-Elliott, B., Desmond, E.P., Hall, G.S., Heifets, L., Pfyffer, G.E., (2003) Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes: approved standard: NCCLS; Kokuto, H., Sasaki, Y., Yoshimatsu, S., Mizuno, K., Yi, L., Mitarai, S., Detection of Mycobacterium tuberculosis in fecal specimens from adults diagnosed with pulmonary tuberculosis using the XpertMTB/RIF test (2015) Open Forum Infectious Diseases, , Oxford University Press; Nicol, M.P., Spiers, K., Workman, L., Isaacs, W., Munro, J., Black, F., Xpert MTB/RIF testing of stool samples for the diagnosis of pulmonary tuberculosis in children (2013) Clinical Infectious Diseases, 57 (3), pp. e18-e21; Zweig, M.H., Campbell, G., Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine (1993) Clinical chemistry, 39 (4), pp. 561-577; Brodie, D., Schluger, N.W., The diagnosis of tuberculosis (2005) Clinics in chest medicine, 26 (2), pp. 247-271; Triasih, R., Graham, S.M., Limitations of the Indonesian Pediatric Tuberculosis Scoring System in the context of child contact investigation (2011) Paediatr Indones, 51, pp. 332-337; Lawn, S.D., Nicol, M.P., Xpert� MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance (2011) Future microbiology, 6 (9), pp. 1067-1082; Steingart, K.R., Schiller, I., Horne, D.J., Pai, M., Boehme, C.C., Dendukuri, N., Xpert� MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults (2014) Cochrane Database Syst Rev, p. 1; Chang, K., Lu, W., Wang, J., Zhang, K., Jia, S., Li, F., Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis (2012) Journal of Infection, 64 (6), pp. 580-588; Welday, S.H., (2015) Gene Xpert Testing Of Stool Samples for the Diagnosis of Pulmonary Tuberculosis in Children Less Than 15 Years in Hospitals In and Around Nairobi; Nicol, M.P., Workman, L., Isaacs, W., Munro, J., Black, F., Eley, B., Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study (2011) The Lancet infectious diseases, 11 (11), pp. 819-824 | |
dcterms.source | Scopus |